mots-c and tirzepatide mots c vs What Is MOTS-c? A Medical Provider's Guide to the Mitochondrial Peptide for Metabolism, Energy, Longevity Using MOTS-c in conjunction with

Only patients who lost 5% body weight during the 12-week intensive lifestyle lead-in period entered the 72-week randomized treatment period

Chan Nature Metabolism.2024

The tirzepatide doses of 10 and/or 15 mg demonstrated superiority compared to placebo for the coprimary endpoints percentage body weight reductions from baseline at week 72 and the proportion of patients achieving 5% body weight reduction at week 72

The FDA has received more than 545 adverse event reports linked to compounded tirzepatide alone, and grey market products bypass even the minimal oversight that compounding pharmacies provide

No randomized controlled trials have evaluated tirzepatide use in pregnant patients, so medical professionals cannot confidently predict how the medication might affect fetal development, placental function, or maternal metabolic changes during pregnancy